REE Automotive Announces Commencement of Exchange Offer and Consent Solicitation Relating to Warrants

Written by Customer Service on August 25, 2022. Posted in Public Companies.

TEL AVIV, Israel, Aug. 25, 2022 (GLOBE NEWSWIRE) — REE Automotive Ltd. (NASDAQ: REE) (“REE” or the “Company”), an automotive technology leader and provider of electric vehicle (EV) platforms, today announced that it has commenced an exchange offer (the “Offer”) and consent solicitation (the “Consent Solicitation”) relating to its outstanding (i) public warrants to purchase Class A ordinary shares of the Company, without par value (the “Class A ordinary shares”), which warrants trade on the Nasdaq Stock Market (“Nasdaq”) under the symbol “REEAW”(the “public warrants”) and (ii) related private placement warrants to purchase Class A ordinary shares (the “private placement warrants” and, together with the public warrants, the “warrants”). The warrants were assumed by REE in connection with its business combination with 10X Capital...

Razor Energy Corp. Announces Second Quarter 2022 Results

Written by Customer Service on August 25, 2022. Posted in Earnings Releases And Operating Results.

CALGARY, Alberta, Aug. 25, 2022 (GLOBE NEWSWIRE) — Razor Energy Corp. (“Razor” or the “Company”) (TSXV: RZE) announces its second quarter 2022 financial and operating results. Selected financial and operational information is outlined below and should be read in conjunction with Razor’s unaudited interim condensed consolidated financial statements and management’s discussion and analysis for the three and six months ended June 30, 2022 which are available on SEDAR at www.sedar.com and the Company’s website www.razor-energy.com. All amounts are expressed in Canadian dollars. Certain metrics, including those expressed on an adjusted basis, are non-IFRS and other financial measures. See “Non-IFRS and Other Financial Measures” below. RECENT HIGHLIGHTS Increased Production: Completed work on a group pipeline and associated wells in...

Blueberries Medical Reports 2022 Q2 Financial Results and Provides Corporate and Operations Update

Written by Customer Service on August 25, 2022. Posted in Earnings Releases And Operating Results.

TORONTO, Aug. 25, 2022 (GLOBE NEWSWIRE) — Blueberries Medical Corp. (CSE: BBM) (OTC: BBRRF) (FRA: 1OA), the Canadian parent of Blueberries S.A.S. (“BBSAS”), the premier Latin American licensed cultivator and producer of medicinal cannabis and medicinal-grade cannabis extracts, (together the “Company” or “Blueberries“), is pleased to report its financial results for the quarter ended on June 30, 2022. Today, Blueberries has filed its unaudited condensed interim consolidated financial statements and related management’s discussion and analysis, both of which are available on Blueberries’ profile at www.sedar.com. All amounts are expressed in Canadian dollars, unless otherwise noted. Blueberries Medical Corp. continues to deploy its strategy by focusing on multiple key revenue-generating activities while reducing...

WSFS Financial Corporation’s A- Senior Unsecured Debt Rating Affirmed by KBRA, After the Successful Combination with Bryn Mawr Trust

Written by Customer Service on August 25, 2022. Posted in Mergers And Acquisitions.

WILMINGTON, Del., Aug. 25, 2022 (GLOBE NEWSWIRE) — Kroll Bond Rating Agency (KBRA) has reaffirmed the senior unsecured debt rating of A- for WSFS Financial Corporation (NASDAQ: WSFS) (“WSFS” or “the Company”). KBRA also reaffirmed WSFS’ subordinated debt rating of BBB+ and a short-term debt rating of K2. WSFS Bank, the Company’s primary subsidiary, received strong credit ratings as well, including A ratings for both senior unsecured debt and deposit, a subordinated debt rating of A-, and the short-term debt and deposit ratings of K1. KBRA’s debt ratings for WSFS can be accessed here. “For the seventh consecutive year, WSFS has received a strong debt rating. The rating reflects the strength of our diversified business model, our successful integration of Bryn Mawr Trust, our track record of profitable organic and non-organic growth,...

Report On Financial Results For The Three And Six Months Ended June 30, 2022

Written by Customer Service on August 25, 2022. Posted in Earnings Releases And Operating Results.

TORONTO, Aug. 25, 2022 (GLOBE NEWSWIRE) — Mitchell Cohen, Chief Executive Officer and President of Urbanfund Corp. (TSX-V: UFC) (“Urbanfund” or the “Company”), confirmed today that the Company has filed its financial statements for the three and six months ended June 30, 2022 (the “Consolidated Financial Statements”) and corresponding Management’s Discussion and Analysis (“MD&A”). BUSINESS OVERVIEW AND STRATEGY Business Overview Urbanfund Corp. is an incorporated entity listed on the TSX Venture Exchange (“TSX-V”) under the symbol UFC. The Company is a reporting issuer in Alberta, British Columbia and Ontario. Urbanfund’s focus is to invest in Canadian real estate and real estate related projects with a focus on a mix of both residential and commercial properties. The Company’s assets are located in Toronto, Brampton, Belleville,...

CVW CleanTech Announces Q2 2022 Results

Written by Customer Service on August 25, 2022. Posted in Earnings Releases And Operating Results.

CALGARY, Alberta, Aug. 25, 2022 (GLOBE NEWSWIRE) — CVW CleanTech Inc. (the “Company” or “CVW CleanTech”) (TSX-V: CVW) is pleased to announce its operating and financial results the three and six month periods ended June 30, 2022. For complete details, please refer to the condensed interim financial statements and the associated Management Discussion and Analysis for the period ended June 30, 2022, available on SEDAR: (www.sedar.com) or on the Company’s website: www.CVWCleanTech.com/ Management and the Board of Directors continue to seek to commercialize CVW CleanTech’s technologies, to a broader range of partners than previously contemplated. Further, we are considering application of its technologies and financial structuring to a broader clean tech industry. Financial highlights The cash balance...

Koss Corporation Releases Fourth Quarter Results

Written by Customer Service on August 25, 2022. Posted in Earnings Releases And Operating Results.

MILWAUKEE, Aug. 25, 2022 (GLOBE NEWSWIRE) — Koss Corporation (NASDAQ: KOSS) (the “Company”), the U.S. based high-fidelity headphone company, has reported its results for the fourth quarter ended June 30, 2022. Sales for the fourth fiscal quarter were $4,191,761, a decline of 22.7% compared to $5,420,471 for the same period in the prior year. The net income for the three months ended June 30, 2022 was $385,595, which is an increase over the net income of $331,943 for the same three month period one year ago. Both basic and diluted income per common share for the quarter were $0.04 compared to a basic income per common share of $.04 and a diluted income per common share of $0.03 for the three-month period one year ago. “We saw a decline in sales for the quarter,” Michael J. Koss, Chairman and CEO, said today. “We appear to be experiencing...

BlackRock® Canada Announces Final August Cash Distributions for the iShares® Premium Money Market ETF

Written by Customer Service on August 25, 2022. Posted in Dividend Reports And Estimates.

TORONTO, Aug. 25, 2022 (GLOBE NEWSWIRE) — BlackRock Asset Management Canada Limited (“BlackRock Canada”), an indirect, wholly-owned subsidiary of BlackRock, Inc. (NYSE: BLK), today announced the final August 2022 cash distributions for the iShares Premium Money Market ETF. Unitholders of record on August 26, 2022 will receive cash distributions payable on August 31, 2022. Details regarding the final “per unit” distribution amounts are as follows: Fund Name Fund Ticker Cash Distribution Per Unit ($) iShares Premium Money Market ETF CMR 0.088 Further information on the iShares ETFs can be found at http://www.blackrock.com/ca. About BlackRock BlackRock’s purpose is to help more and more people experience financial well-being. As a fiduciary to investors and a leading provider of financial technology, we help millions of people...

Molecular Partners Reports Corporate Highlights and H1 2022 Financials

Written by Customer Service on August 25, 2022. Posted in Earnings Releases And Operating Results.

Continued development of MP0317, with initial clinical data from Phase 1 study expected in the second half of 2022 Initiation of Phase 1 study for MP0533 expected by year end Continued progression of proprietary DARPin-conjugated radioligand therapeutics; innate immune cell engagers; next-generation T-cell engagers; and antiviral DARPins MP0310 Phase 1 enrollment complete; no additional studies currently planned In January 2022, Molecular Partners received a payment of CHF 150 million from Novartis to license ensovibep Novartis is responsible for further development, manufacturing, and commercialization activities. An application for Emergency Use Authorization (EUA) was submitted to the U.S. Food and Drug Administration (FDA) by Novartis for ensovibep Cash position of CHF 285.1 million as of June 30, 2022, anticipated to support operations...

Emily Melton to Step Down from Shift’s Board of Directors

Written by Customer Service on August 25, 2022. Posted in Public Companies.

SAN FRANCISCO, Aug. 25, 2022 (GLOBE NEWSWIRE) — Shift Technologies, Inc. (Nasdaq: SFT) announced today that Emily Melton, Lead Director who has served on the company’s Board since 2014, will be stepping down from the Board, effective August 31. Jason Krikorian, company Director since 2018, will succeed Melton as Lead Director. “Every entrepreneur should be so lucky as to have an early investor like Emily – she has been an invaluable partner and I could not imagine this journey without her,” said George Arison, Shift’s co-founder and Board Chair. “Since co-leading our Series A, she has been a wonderful supporter, advisor, and mentor to all the leaders at Shift. Thanks to Emily’s sound business judgment, generosity of time, and deep experience in company building, I’ve become a much better founder and leader. I will miss her...

Day: August 25, 2022

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Cookie Notice